Charles River Laboratories International Inc. and Wheeler Bio Inc., a contract development and manufacturing organization, recently announced an agreement to implement RightSourceSM at Wheeler Bio’s current good manufacturing practice (cGMP) biologics manufacturing facility in Oklahoma City.
“We are thrilled to have RightSource on-site at Wheeler Bio in Oklahoma City,” said Jesse McCool, Wheeler Bio co-founder and chief executive officer. “This initiative adds considerable value to our growing base of clients progressing important therapeutic antibodies and other biologics from discovery to clinical development. It is reassuring knowing that we can rely on Charles River to deliver this important testing service and appropriate levels of quality oversight and compliance. In addition to access to the platform embedded within our operations, we can deliver our clients expedited access to other Charles River services such as viral clearance studies and cell line characterization. This collaboration contributes significantly to our goal of cost-effectively increasing speed and efficiency of delivery of important therapeutics to patients across the globe.”
Deployed on-site at a client’s facility, RightSource is a flexible biologics testing lab operated and managed by Charles River, which aims to make quality control more accessible to a broader reach of companies.
Through this model, Charles River, in close collaboration with Wheeler, will set up a cGMP testing lab on-site at Wheeler’s facility. This platform-based satellite lab will be operated by Charles River employees who will utilize Charles River’s quality management systems, test methods and standard operating procedures to support all QC testing needs for Wheeler and its third-party clients.
